Abstract
Forty-three patients, including 13 patients with metastatic breast cancer, each received an individuallyspecified combination of either Adriamycin(24 patients) or mitomycin-C(19 patients) conjugated murine monoclonal ant ibodies. Tumors were typed using a panel of antibodies with both immunohistochemistry and flow cytometry. Cocktails composed of 2–6 antibodies were selected based on binding greater than 80% of the malignant cells in the biopsy specimen. These monoclonal antibody cocktails were drug conjugated and administered intravenously.
Seventeen out of twenty-four patients had reactions (fever, chills, pruritis and skin rash) to the administration of Adriamycin immunoconjugates, but these were tolerable in all but two patients. In several patients it was demonstrated that there was limited antigenic drift among various biopsies within the same patient over time. Up to 1 gram of Adriamycin and up to 5 grams of monoclonal antibody were administered. Two patients with breast carcinoma had depinite improvement in ulcerating skin lesions. The limiting factor appeared to be a variable dissociation of active Adriamycin from the antibody which unpredictably caused hemopoietic depression.
Similar findings were noted in 19 patients with mitomycin-C conjugates. Thrombocytopenia at a 60mg dose of mitomycin-C in this schedule was dose limiting. Preliminary serological evidence suggests that the development of an IgM antibody which is specific against the mouse monoclonal antibody has the specificity and sensitivity to predict clinical reactions. These antibodies were quantitatively less in mitomycin-C than Adriamycin treated patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bernhard, M.I., Hwang, K.M., Foon, K.A. et al.: Localization of Indium and Iodine-Labeled Monoclonal Ant ibod ies in Guinea Pigs Bearing Line 10 Hepatocarcino-ma Tumors.Cancer Research 43 :4429–4433, 1983.
Goldenberg, D.M., De Land, F. H.: History and Status of Tumor Imaging and Radiolabeled Antibodies: J. Biol. Resp. Modif. 1: 121–136, 1982.
Avner, B. P., Liao, S.K., Avner, B., et al.: Therapeutic Murine Monoclonal Antibodies Developed for Individual Cancer Patients. J. Biol. Resp. Modif. (In Press), 1988.
Liao, S.K., Meranda, C., Avner, B.P., et al.: Immunohistochemical Phenotyping of Human Solid Tumors with Monoclonal Antibodies in Devising Biotherapeutic Strategies.Cancer Immunol. and Immunother.(In Press) 1989.
Ogden, J.R., Leung, K. Kunda, S.A., Telander, M.W., Avner, B. P., Liao, S.K., Thurman, G.B., Oldham, R.K.: Immunoconj uga tes of Doxorub ic in and Murine Anti-Human Breast Carcinoma Monoclonal Antibodies Prepared via an N-Hydroxysucc in imide Active Ester Intermediate of Cisaconityl Doxorubicin: Preparation and In Vivo Cytoxicity. Molecular Biotherapy (In Press). 1988
Orr, D.W., Oldham, R.K., and Lewis, M.: Phase I Trial of Mitomycin-C Immunoconj uga tes. (In Preparation), 1988.
Avner, B. P., Gaydos, B., Liao, S.K., Thurman, G.B., Oldham, R.K.: Characterization of a Method Using Viable Human Target Cells as the Solid Phase in a Cell Concentration Fluorescent Immunoassay(CCFIA) for Screening of Monoclonal Antibodies and Hybridoma Supernatants. J. Immunol. Meth. 113: 123–135, 1988.
Avner, B., Swindell, L., Sharp, E., Liao, S.K., Avner, B. P., Oldham, R.K.: Monitoring of Patient Immune Reponses to Intravenous Therapy with Murine Monoclonal Antibodies Conjugated to Adriamyc in: Relevance to Clinical Events. Cancer Research(Submitted). 1988
Oldham, R.K., Lewis, M., Orr, D.W., Avner, B. P., Liao, S.K., Ogden, J., Avner, B., and Birch, R.: Adriamycin Custom-Tailored Immunoconjugates in the Treatment of Human Malignancies.Molecular Biotherapy(In Press), 1988.
Houghton, A., Mintzer, D., Cordon-Cardo, C., et al: Mouse Monoclonal IgG-3 Antibody Detecting GD-3 Ganglioside: A Phase I Trial in Patients with Malignant Melanoma.Proc. Natl. Acad. Sci. (USA), 82 :1242–1246, 1985.
Oldham, R., Foon, K., Morgan, C., et al.: Monoclonal Antibody Therapy of Malignant Melanoma: In Vivo Locatl izat ion and Cutaneous Metastases After Intravenous Administration. J. Clin. Oncol. 2: 1235–1244, 1984.
De Nardo, S., De Nardo, G., O’Grady, L., et al: Pilot Studies of Radioimmunotherapy of B-Cell Lymphoma and Leukemia Using I-131 Lym-1 Monoclonal Antibody:Ant ibod. Immunoconj. Radiopharm. 1(1): 17 – 33, 1988.
Rosen, S., Zimmer, A., Goldman-Leikin, R., et al: Radioimmunodetection and Radioimmunotherapy of Cutaneous TCell Lymphomas Using I-311 — Labeled Monoclonal Antibody: An Illinois Cancer Counsel Study. J. Clinical Oncology 5(4): 562–73, 1987.
Epenetos, A., Monroe, A., Stewart, S., et al: Antibody Guided Radiation of Advanced Ovarian Cancer with Intraperitoneally Administered Radiolabeled Monoclonal Antibodies. J. Clin. Oncol. 5(12): 1890–1899, 1987.
Spitler, L., Del Rio, M., Khentizan, A., et al: Therapy of Patients with Malignant Melanoma Using a Monoclonal Anti-Melanoma Antibody-Ricin A Chain Immunotoxin:Cancer Research 47: 1717 –1723, 1987.
Oldham, R. K.: Monoclonal Antibodies — Does Suf f ic ient Selectivity to Cancer Cells Exist for Therapeutic Application? J. Biol. Resp. Modif. 6 :277–284, 1987.
Oldham, R.K.: Immunoconjugates — Drugs and Toxins. In: Oldham, R.K.(Ed.)Principles of Cancer Biotherapy. Raven Press, New York, pp. 319–335, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Oldham, R.K., Liao, SK., Ogden, J.R., Hubbard, W.H. (1989). Individually Specified Drug Immunoconjugates in Cancer Treatment. In: Ceriani, R.L. (eds) Breast Cancer Immunodiagnosis and Immunotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1296-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1296-4_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1298-8
Online ISBN: 978-1-4757-1296-4
eBook Packages: Springer Book Archive